Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-28 01:38:46 - browse：6116

FDA-Blood Sugar Monitor — The FDA has approved a device from Abbott that continuously monitors diabetics’ blood sugar levels without requiring backup finger prick tests. Abbott Laboratories via AP

U.S. regulators have approved the first continuous blood sugar monitor for diabetics that doesn’t need backup finger prick tests.

Current models require users to test a drop of blood twice daily to calibrate, or adjust, the monitor.

The pain of finger sticks and the cost of testing supplies discourage many people from keeping close tabs on their blood sugar, which is needed to manage insulin use and adjust what they eat.

Abbott’s new FreeStyle Libre Flash Glucose Monitoring System, approved Wednesday by the Food and Drug Administration, uses a small sensor attached to the upper arm. Patients wave a reader device over it to see the current blood sugar level and changes over the past eight hours.

Most of the 30 million Americans with diabetes use standard glucose meters, which require multiple finger pricks each day and only show current sugar level. More-accurate continuous glucose monitoring devices are used by about 345,000 Americans.

Newsletters

Sign up for Morning Rounds

Your daily dose of news in health and medicine.

Please enter a valid email address. Privacy Policy

But most don’t do the finger pricks to calibrate them and may get inaccurate readings, said Dr. Timothy Bailey, who helped test FreeStyle Libre.

“We’re able to lower blood sugar safely” with this technology, said Bailey, director of the Advanced Metabolic Care and Research Institute in California. He receives consulting fees from various diabetes device makers.

Too-high blood sugar levels can damage organs and lead to heart attacks, strokes, blindness and amputations. Very low blood sugar can cause seizures, confusion and loss of consciousness.

Abbott’s device was approved for adults with type 1 or type 2 diabetes and should be available in pharmacies within months. The company, based near Chicago, did not disclose the price of the reader or the sensors.

Abbott’s system can’t be used with an insulin pump, a device worn against the skin that allows users to inject insulin as needed, but the company is planning improvements to eventually enable that.

Rival Medtronic this spring launched a device in which the insulin pump automatically responds to blood sugar changes recorded by the sensor and either withholds or injects insulin as needed.

— Linda A. Johnson

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： How the first Native Hawaiian psychiatrist helped diversify medicine

leisure time

WSS

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

DeSantis wants to import drugs. Biden’s FDA blasted his plan

National associations that represent hospice owe an apology

How a Boston hospital is priming medical residents to use GPT

As obesity drug market grows, telehealth companies court payers

Sanders wants to replace patents with prizes for drug inventions

hotspot

Wikipedia

Sign up for Morning Rounds

entertainment

New air purifier tech could be key to improving indoor air quality

Telehealth startups are trying to fill the menopause care vacuum

Supreme Court strikes down use of affirmative action

Trans patients at the end of life deserve respect and dignity

Jerome Adams on the need for new antivirals for Covid

Vivek Ramaswamy made waves in the debate, much as in biotech

Anesthesiologist group: stop taking Ozempic before surgery

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Jerome Adams on the need for new antivirals for Covid

Vivek Ramaswamy made waves in the debate, much as in biotech

explore

National associations that represent hospice owe an apology

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Hormonal contraceptives don’t actually treat endometriosis

Scientists grapple with ethics of stem cell research

Roche's accidental data boosts hopes for anti

FDA greenlights medical device to combat bladder issues

hotspot

leisure time

leisure time

focus